Waaree Energies · risk themes across the available quarters.
Bear-case history
A US Customs probe under CBP is active and early-stage regarding sourcing of cells used in modules exported to the US. Management states internal review shows limited potential liability, but the outcome is uncertain. The company confirmed it is NOT using India-manufactured cells for US modules currently, sourcing from compliant geographies to minimize tariff exposure.
Finished goods inventory surged to ~₹1,300 crore (vs. normal ~₹300-400 crore) due to shipped-but-not-delivered export orders. This creates a working capital drag. Management expects this to unwind in H2, normalizing cash generation.
Duty costs are partially passed through to customers via contracts (some with change-of-law clauses), but tariff minimization depends on sourcing geography. Higher export mix drove other expenses to 9% of revenue (vs. normal 6-6.5%), which should moderate but remains a negotiating risk.
With ~35-40 GW of cell capacity expected in India by June 2026, pricing for DCR modules may face downward pressure. Management acknowledged this but expects margins to be maintained in the 22-25% range given favorable ALMM dynamics and cost structure.
The company is simultaneously ramping up battery storage (20 GWh), inverters (4 GW total), transformers (20,000 MVA), and electrolyzers (1 GW), creating execution complexity across multiple new facilities with different technology domains.
Management provided strong revenue growth guidance but notably absent was any explicit EBITDA margin guidance or commentary on margin trajectory despite EBITDA growing 167% YoY, raising questions about sustainability of margins as the company scales rapidly.
While Waaree secured non-Chinese polymeric supply chain through Oman investment, questions remain about other critical raw material sourcing stability and pricing volatility given the company's massive production ramp.
With the battery gigafactory requiring significant capital and multiple expansion programs underway simultaneously, analyst questioned how management prioritizes capital allocation across competing strategic initiatives and maintains balance sheet strength.